Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants

S Jallow; A Alabi; R Sarge-Njie; K Peterson; H Whittle; T Corrah; A Jaye; M Cotten; G Vanham; SJ McConkey; S Rowland-Jones; W Janssens

doi:10.1128/JCM.01654-08

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants

S Jallow, A Alabi, R Sarge-Njie, K Peterson, H Whittle, T Corrah, A Jaye, M Cotten, G Vanham, SJ McConkey, S Rowland-Jones, W Janssens

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Original language	English
Journal	Journal of Clinical Microbiology
Volume	47
Issue number	7
Pages (from-to)	2200-2208
Number of pages	9
ISSN	0095-1137
DOIs	https://doi.org/10.1128/JCM.01654-08
Publication status	Published - 2009

Keywords

B780-tropical-medicine
Viral diseases
AIDS
HIV-2
Dual infection
HIV-1
Drug therapy
Antiretrovirals
HAART
Zidovudine
Lamivudine
Lopinavir
Ritonavir
Efficacy
Long term
Treatment outcomes
Viral load
Adverse effects
Mutations
Drug resistance
Gambia
Africa-West

Access to Document

10.1128/JCM.01654-08

http://lib.itg.be/pdf/itg/2009/2009jcmi2200.pdf

Cite this

Jallow, S., Alabi, A., Sarge-Njie, R., Peterson, K., Whittle, H., Corrah, T., Jaye, A., Cotten, M., Vanham, G., McConkey, SJ., Rowland-Jones, S., & Janssens, W. (2009). Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants. Journal of Clinical Microbiology, 47(7), 2200-2208. https://doi.org/10.1128/JCM.01654-08

@article{1542113eeb5b41c0ac1b43c18e6275a8,

title = "Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants",

keywords = "B780-tropical-medicine, Viral diseases, AIDS, HIV-2, Dual infection, HIV-1, Drug therapy, Antiretrovirals, HAART, Zidovudine, Lamivudine, Lopinavir, Ritonavir, Efficacy, Long term, Treatment outcomes, Viral load, Adverse effects, Mutations, Drug resistance, Gambia, Africa-West",

author = "S Jallow and A Alabi and R Sarge-Njie and K Peterson and H Whittle and T Corrah and A Jaye and M Cotten and G Vanham and SJ McConkey and S Rowland-Jones and W Janssens",

note = "ITG-M1B; ITG-M9A; ITG-MLA; MICRO; U-VIROL; JIF; DOI; PDF; DSPACE",

year = "2009",

doi = "10.1128/JCM.01654-08",

language = "English",

volume = "47",

pages = "2200--2208",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "7",

}

Jallow, S, Alabi, A, Sarge-Njie, R, Peterson, K, Whittle, H, Corrah, T, Jaye, A, Cotten, M, Vanham, G, McConkey, SJ, Rowland-Jones, S & Janssens, W 2009, 'Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants', Journal of Clinical Microbiology, vol. 47, no. 7, pp. 2200-2208. https://doi.org/10.1128/JCM.01654-08

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants. / Jallow, S; Alabi, A; Sarge-Njie, R et al.
In: Journal of Clinical Microbiology, Vol. 47, No. 7, 2009, p. 2200-2208.

Research output: Contribution to journal › A1: Web of Science-article › peer-review

TY - JOUR

T1 - Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants

AU - Jallow, S

AU - Alabi, A

AU - Sarge-Njie, R

AU - Peterson, K

AU - Whittle, H

AU - Corrah, T

AU - Jaye, A

AU - Cotten, M

AU - Vanham, G

AU - McConkey, SJ

AU - Rowland-Jones, S

AU - Janssens, W

N1 - ITG-M1B; ITG-M9A; ITG-MLA; MICRO; U-VIROL; JIF; DOI; PDF; DSPACE

PY - 2009

Y1 - 2009

KW - B780-tropical-medicine

KW - Viral diseases

KW - AIDS

KW - HIV-2

KW - Dual infection

KW - HIV-1

KW - Drug therapy

KW - Antiretrovirals

KW - HAART

KW - Zidovudine

KW - Lamivudine

KW - Lopinavir

KW - Ritonavir

KW - Efficacy

KW - Long term

KW - Treatment outcomes

KW - Viral load

KW - Adverse effects

KW - Mutations

KW - Drug resistance

KW - Gambia

KW - Africa-West

U2 - 10.1128/JCM.01654-08

DO - 10.1128/JCM.01654-08

M3 - A1: Web of Science-article

SN - 0095-1137

VL - 47

SP - 2200

EP - 2208

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 7

ER -

Jallow S, Alabi A, Sarge-Njie R, Peterson K, Whittle H, Corrah T et al. Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants. Journal of Clinical Microbiology. 2009;47(7):2200-2208. doi: 10.1128/JCM.01654-08